Home - Products - Chromatin/Epigenetic - Sirtuin - 6'-O-beta-D-Glucosylgentiopicroside

6'-O-beta-D-Glucosylgentiopicroside

CAS No. 115713-06-9

6'-O-beta-D-Glucosylgentiopicroside( —— )

Catalog No. M17842 CAS No. 115713-06-9

1. 6'-O-beta-D-Glucosylgentiopicroside may have antifungal activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 141 In Stock
5MG 103 In Stock
10MG 170 In Stock
25MG 282 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    6'-O-beta-D-Glucosylgentiopicroside
  • Note
    Research use only, not for human use.
  • Brief Description
    1. 6'-O-beta-D-Glucosylgentiopicroside may have antifungal activity.
  • Description
    6'-O-beta-D-Glucosylgentiopicroside may have antifungal activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Sirtuin
  • Recptor
    Antifungal
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    115713-06-9
  • Formula Weight
    518.46
  • Molecular Formula
    C22H30O14
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (192.88 mM)
  • SMILES
    C=CC1C(OC=C2C1=CCOC2=O)OC3C(C(C(C(O3)COC4C(C(C(C(O4)CO)O)O)O)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Sirt2-IN-1

    Sirt2-IN-1 is a inhibitor of sirtuin 2 (Sirt2)(IC50 of 163 nM).

  • Nicotinamide ribosid...

    Nicotinamide riboside increases NAD[+] levels and activates SIRT1 and SIRT3, culminating in enhanced oxidative metabolism and protection against high fat diet-induced metabolic abnormalities.

  • ADTL-SA1215

    ADTL-SA1215 is a selective SIRT3 activator with SIRT3 deacetylase activity that inhibits the proliferation and migration of human breast cancer MDA-MB-231 cells through the SIRT3-driven autophagy/mitochondrial autophagy signaling pathway, and can be used in the study of triple negative breast cancer.